Is ASBP research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.

ASBP (Aspire Biopharma Holdings, Inc. Common Stock) Stock Analysis - Financials

Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is a publicly traded Healthcare sector company. As of September 8, 2026, ASBP trades at $9.00 with a market cap of $12.44M and a P/E ratio of 0.00. ASBP moved +0.00% today. Year to date, ASBP is -94.40%; over the trailing twelve months it is -98.56%. Its 52-week range spans $3.31 to $11,832.00. Rallies surfaces ASBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are ASBP's key financials?

ASBP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ASBP recently traded at $9.00. Market cap is $12.44M. P/E ratio is 0.00. Revenue is $6.20K.

ASBP Key Metrics

Key financial metrics for ASBP
Metric	Value
Price	$9.00
Market Cap	$12.44M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.16%
52-Week High	$11,832.00
52-Week Low	$3.31
Volume	2.97K
Avg Volume	0
Revenue (TTM)	$6.20K
Net Income	$-24.48M
Gross Margin	0.00%

ASBP Analyst Consensus

ASBP analyst coverage data. Average price target: $0.00.

Common questions about ASBP

What are ASBP's key financials?: ASBP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ASBP recently traded at $9.00. Market cap is $12.44M. P/E ratio is 0.00. Revenue is $6.20K.
Is ASBP research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ASBP. It does not provide personalized investment advice.